Macfarlane et al Blarcamesine Phase IIb III JPAD 2025

Anavex Life Sciences Corp. published this content on January 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 05, 2025 at 15:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]